Status epilepticus

Indian Journal of Pediatrics

Volumn 78, Issue 2, 2011, Pages 219-226

  Raj, Dinesh ^a   Gulati, Sheffali ^a   Lodha, Rakesh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Benzodiazepine; Children; Phenobarbitone; Phenytoin; Status epilepticus .Valproate

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; KETAMINE; LORAZEPAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PROPOFOL; THIOPENTAL; TOPIRAMATE; VALPROIC ACID;

ARTICLE; ASPIRATION PNEUMONIA; ATAXIA; BLOOD FLOW; BRAIN DISEASE; CONTINUOUS INFUSION; DEATH; DISEASE DURATION; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; EPILEPTIC STATE; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HUMAN; HYPERAMMONEMIA; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; KIDNEY FAILURE; LETHARGY; LIVER TOXICITY; LOADING DRUG DOSE; LUNG EDEMA; METABOLIC ACIDOSIS; NEUROPROTECTION; PATHOGENESIS; RESPIRATION DEPRESSION; RHABDOMYOLYSIS; SEDATION; SHOCK; SIDE EFFECT; TACHYCARDIA; THROMBOPHLEBITIS;

ANTICONVULSANTS; BENZODIAZEPINES; CHILD; CLINICAL PROTOCOLS; FRUCTOSE; GABA MODULATORS; HUMANS; KETAMINE; MIDAZOLAM; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PIRACETAM; PROPOFOL; STATUS EPILEPTICUS; THIOPENTAL; VALPROIC ACID;

EID: 79953848235     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-010-0291-y     Document Type: Article

References (60)

1. Working Group on Status Epilepticus. Treatment of CSE: Recommendations of Epilepsy Foundation of America's working group of SE. JAMA. 1993;270:854-9.
2. Nevander G, Ingvar M, Auer R, Siesjö BK. Status epilepticus in well-oxygenated rats causes neuronal necrosis. Ann Neurol. 1985; 18:281-90. (Pubitemid 15023100)
3. Siesjo B, Wieloch T. Epileptic brain damage. Pathophysiology and neurochemical pathology. In: Delgado-Escueta AV, Ward Jr AA, Woodbury DM, Porter RJ, editors. Advances in neurology, vol. 44, basic mechanisms of the epilepsies: Molecular and cellular approaches. New York: Raven Press; 1986. p. 813-47.
4. Hauser WA. Status epilepticus: Epidemiologic considerations. Neurology. 1990;40:9-13.
5. Theodore WH, Porter RJ, Albert P, et al. The secondarily generalized tonic-clonic seizure: A videotape analysis. Neurology. 1994;44:1403-7. (Pubitemid 24247426)
6. Chin RFM, Neville BGR, Peckham C, et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: Prospective population based study. Lancet. 2006; 368:222-9. (Pubitemid 44041084)
7. Shinnar S, Pellock JM, Moshé SL, et al. In whom does status epilepticus occur: Age-related differences in children. Epilepsia. 1997;38:907-14. (Pubitemid 27323600)
8. Noe KH, Manno EM. Mechanisms underlying status epilepticus. Drugs Today (Barc). 2005;41:257-66. (Pubitemid 40991155)
9. Nandhagopal R. Generalised convulsive status epilepticus: An overview. Postgrad Med J. 2006;82:723-32.
10. Lothman E. The biochemical basis and pathophysiology of status epilepticus. Neurology. 1990;40:13-23.
11. Naylor DE, Liu H, Wasterlain CG. Trafficking of GABAA receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci. 2005;25:7724-33. (Pubitemid 41208643)
12. Terunuma M, Xu J, Vithlani M, et al. Deficits in phosphorylation of GABAA receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus. J Neurosci. 2008;28:376-84.
13. Goodkin HP, Joshi S, Mtchedlishvili Z, Brar J, Kapur J. Subunitspecific trafficking of GABAA receptors during status epilepticus. J Neurosci. 2008;28:2527-38. (Pubitemid 351348210)
14. Rajasekaran K, Zanelli SA, Goodkin HP. Lessons from the laboratory: The pathophysiology, and consequences of status epilepticus. Semin Pediatr Neurol. 2010;17:136-43.
15. Chin RF, Verhulst L, Neville BG, Peters MJ, Scott RC. Inappropriate emergency management of status epilepticus in children contributes to need for intensive care. J Neurol Neurosurg Psychiatry. 2004;75:1584-8. (Pubitemid 39430611)
16. Chen JW, Naylor DE, Wasterlain CG. Advances in the pathophysiology of status epilepticus. Acta Neurol Scand Suppl. 2007; 186:7-15. (Pubitemid 46376165)
17. Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG. Timedependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res. 1998;814:179-85. (Pubitemid 29023424)
18. Appleton R, Macleod S, Martland T. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev. 2008;3: CD001905.
19. McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: A randomised controlled trial. Lancet. 2005;366:205-10. (Pubitemid 40981047)
20. Bhattacharyya M, Kalra V, Gulati S. Intranasal midazolam vs rectal diazepam in acute childhood seizures. Pediatr Neurol. 2006;34:355-9.
21. Mittal P, Manohar R, Rawat AK. Comparative study of intranasal midazolam and intravenous diazepam sedation for procedures and seizures. Indian J Pediatr. 2006;73:975-8.
22. Sreenath TG, Gupta P, Sharma KK, Krishnamurthy S. Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: A randomized controlled trial. Eur J Paediatr Neurol. 2010;14:162-8.
23. Bialer M. Clinical pharmacology of parenteral use of antiepileptic drugs. Epilepsia. 2007;48:46-8. (Pubitemid 350045524)
24. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339:792-8. (Pubitemid 28447452)
25. Mehta V, Singhi P, Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: A randomized controlled trial. J Child Neurol. 2007;22: 1191-7.
26. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure. 2007;16:527-32. (Pubitemid 47209244)
27. Morton LD, O'Hara KA, Coots BP, Pellock JM. Safety of rapid intravenous valproate infusion in pediatric patients. Pediatr Neurol. 2007;36:81-3. (Pubitemid 46176558)
28. Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci. 2004;5:553-64. (Pubitemid 38868551)
29. Gibbs JE, Walker MC, Cock HR. Levetiracetam: Antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus. Epilepsia. 2006;47:469-78.
30. Reiter PD, Huff AD, Knupp KG, et al. Intravenous levetiracetam in the management of acute seizures in children. Pediatr Neurol. 2010;43:117-21.
31. Kirmani BF, Crisp ED, Kayani S, et al. Role of intravenous levetiracetam in acute seizure management of children. Pediatr Neurol. 2009;41:37-9.
32. Abend NS, Monk HM, Licht DJ, Dlugos DJ. Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures. Pediatr Crit Care Med. 2009;10:505-10.
33. Abend NS, Dlugos DJ. Treatment of refractory status epilepticus: Literature review and a proposed protocol. Pediatr Neurol. 2008;38: 377-90. (Pubitemid 351671983)
34. Ozdemir D, Gulez P, Uran N, Yendur G, Kavakli T, Aydin A. Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus. Seizure. 2005;14:129-32. (Pubitemid 40214740)
35. Gilbert DL, Gartside PS, Glauser TA. Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: A meta-analysis. J Child Neurol. 1999;14:602-9. (Pubitemid 29431765)
36. Singhi S, Murthy A, Singhi P, Jayashree M. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol. 2002;17:106-10. (Pubitemid 34498437)
37. Morrison G, Gibbons E, Whitehouse WP. High-dose midazolam therapy for refractory status epilepticus in children. Intensive Care Med. 2006;32:2070-6. (Pubitemid 44833125)
38. Bleck TP. Refractory status epilepticus. Curr Opin Crit Care. 2005; 11:117-20. (Pubitemid 40488609)
39. Lowenstein DH. The management of refractory status epilepticus: An update. Epilepsia. 2006;47:35-40. (Pubitemid 44527133)
40. Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus. Eur J Neurol. 2006;13:445-50. (Pubitemid 43823356)
41. Maytal J, Shinnar S, Moshé SL, Alvarez LA. Low morbidity and mortality of status epilepticus in children. Pediatrics. 1989;83:323-31. (Pubitemid 19071751)
42. Dunn DW. Status epilepticus in children: Etiology, clinical features, and outcome. J Child Neurol. 1988;3:167-73.
43. Eriksson KJ, Koivikko MJ. Status epilepticus in children: Aetiology, treatment, and outcome. Dev Med Child Neurol. 1997;39:652-8. (Pubitemid 27421304)
44. Eriksson K, Baer M, Kilpinen P, Koivikko M. Effects of long barbiturate anaesthesia on eight children with severe epilepsy. Neuropediatrics. 1993;24:281-5. (Pubitemid 23339379)
45. Parviainen I, Uusaro A, Kälviäinen R, Kaukanen E, Mervaala E, Ruokonen E. High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit. Neurology. 2002;59:1249-51. (Pubitemid 35192399)
46. Slatler KD, van Orman CB. Status epilepticus. In: Nichols DG, editor. Roger's textbook of pediatric intensive care. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 912-28.
47. Neuwelt EA, Kikuchi K, Hill SA, Lipsky P, Frenkel E. Barbiturate inhibition of lymphocyte function. Differing effects of various barbiturates used to induce coma. J Neurosurg. 1982;56:254-9. (Pubitemid 12093799)
48. van Gestel JP, Blussé van Oud-Alblas HJ, Malingré M, Ververs FF, Braun KP, van Nieuwenhuizen O. Propofol and thiopental for refractory status epilepticus in children. Neurology. 2005;65:591-2. (Pubitemid 41170720)
49. Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol. 2004;61:1254-9. (Pubitemid 39062680)
50. Crawford TO, Mitchell WG, Fishman LS, Snodgrass SR. Veryhigh- dose phenobarbital for refractory status epilepticus in children. Neurology. 1988;38:1035-40.
51. Lee WK, Liu KT, Young BW. Very-high-dose phenobarbital for childhood refractory status epilepticus. Pediatr Neurol. 2006;34:63-5. (Pubitemid 41821014)
52. Kahriman M, Minecan D, Kutluay E, Selwa L, Beydoun A. Efficacy of topiramate in children with refractory status epilepticus. Epilepsia. 2003;44:1353-6. (Pubitemid 37280381)
53. Blumkin L, Lerman-Sagie T, Houri T, Gilad E, Nissenkorn A, Ginsberg M, et al. Pediatric refractory partial status epilepticus responsive to topiramate. J Child Neurol. 2005;20:239-41. (Pubitemid 40561772)
54. Perry MS, Holt PJ, Sladky JT. Topiramate loading for refractory status epilepticus in children. Epilepsia. 2006;47:1070-1. (Pubitemid 43801519)
55. Singh RK, Stephens S, Berl MM, et al. Prospective study of newonset seizures presenting as status epilepticus in childhood. Neurology. 2010;74:636-42.
56. Freilich ER, Zelleke T, Gaillard WD. Identification and evaluation of the child in status epilepticus. Semin Pediatr Neurol. 2010;17: 144-9.
57. Riviello Jr JJ, Ashwal S, Hirtz D, American Academy of Neurology Subcommittee, Practice Committee of the Child Neurology Society, et al. Practice parameter: Diagnostic assessment of the child with status epilepticus (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2006;67:1542-50. (Pubitemid 44747921)
58. Saengpattrachai M, Sharma R, Hunjan A, et al. Nonconvulsive seizures in the pediatric intensive care unit: Etiology, EEG, and brain imaging findings. Epilepsia. 2006;47:1510-8. (Pubitemid 44393865)
59. Raspall-Chaure M, Chin RF, Neville BG, et al. Outcome of pediatric convulsive status epilepticus: A systematic review. Lancet Neurol. 2006;5:769-79. (Pubitemid 44209399)
60. Logroscino G, Hesdorffer DC, Cascino GD, et al. Long-term mortality after a first episode of status epilepticus. Neurology. 2002;58:537-41. (Pubitemid 34164933)